Healthcare provider profile · identity verified

Michelle Phuong Dinh, MD

Family Practice · SAN JOSE, CA · NPI 1609800960

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	928	251
Atorvastatin Calcium	Atorvastatin Calcium	906	273
Metformin Hcl	Metformin Hcl	644	176
Simvastatin	Simvastatin	517	146
Losartan Potassium	Losartan Potassium	496	140
Omeprazole	Omeprazole	420	128
Fluticasone Propionate	Fluticasone Propionate	379	154
Gabapentin	Gabapentin	333	87
Jardiance	Empagliflozin	295	91
Atenolol	Atenolol	289	80
Triamcinolone Acetonide	Triamcinolone Acetonide	287	128
Hydrochlorothiazide	Hydrochlorothiazide	276	85
Metoprolol Succinate	Metoprolol Succinate	272	75
Glipizide	Glipizide	235	76
Alendronate Sodium	Alendronate Sodium	225	81
Vascepa	Icosapent Ethyl	213	52
Levothyroxine Sodium	Levothyroxine Sodium	181	39
Tamsulosin Hcl	Tamsulosin Hcl	171	48
Benazepril Hcl	Benazepril Hcl	169	49
Furosemide	Furosemide	163	42
Tradjenta	Linagliptin	160	44
Albuterol Sulfate Hfa	Albuterol Sulfate	156	54
Ibuprofen	Ibuprofen	128	49
Pantoprazole Sodium	Pantoprazole Sodium	128	38
Hydrocortisone	Hydrocortisone	123	51
Diclofenac Sodium	Diclofenac Sodium	120	60
Montelukast Sodium	Montelukast Sodium	117	31
Tramadol Hcl	Tramadol Hcl	109	17
Metoprolol Tartrate	Metoprolol Tartrate	108	29
Rybelsus	Semaglutide	106	39
Fosinopril Sodium	Fosinopril Sodium	104	30
Lisinopril	Lisinopril	93	27
Zolpidem Tartrate	Zolpidem Tartrate	93	18
Famotidine	Famotidine	89	34
Allopurinol	Allopurinol	82	21
Carvedilol	Carvedilol	78	20
Eliquis	Apixaban	78	16
Hydralazine Hcl	Hydralazine Hcl	74	17
Loperamide	Loperamide Hcl	71	28
Januvia	Sitagliptin Phosphate	70	19
Glipizide Er	Glipizide	64	20
Ozempic	Semaglutide	61	12
Finasteride	Finasteride	58	18
Baclofen	Baclofen	57	22
Hydroxyzine Hcl	Hydroxyzine Hcl	57	20
Nitroglycerin	Nitroglycerin	57	27
Naproxen	Naproxen	56	23
Rosuvastatin Calcium	Rosuvastatin Calcium	55	17
Clopidogrel	Clopidogrel Bisulfate	51	13
Restasis	Cyclosporine	49	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	48	14
Potassium Chloride	Potassium Chloride	48	14
Arnuity Ellipta	Fluticasone Furoate	45	13
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Mounjaro	Tirzepatide	43	suppressed
Fluocinonide	Fluocinonide	41	17
Pravastatin Sodium	Pravastatin Sodium	41	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	40	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Meclizine Hcl	Meclizine Hcl	38	12
Isosorbide Dinitrate	Isosorbide Dinitrate	36	suppressed
Sertraline Hcl	Sertraline Hcl	36	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	34	suppressed
Trulicity	Dulaglutide	34	suppressed
Azelastine Hcl	Azelastine Hcl	33	11
Ketoconazole	Ketoconazole	33	suppressed
Proctozone-Hc	Hydrocortisone	33	14
Ezetimibe	Ezetimibe	32	11
Valsartan	Valsartan	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Estradiol	Estradiol	28	13
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	25	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	11
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	24	suppressed
Azithromycin	Azithromycin	23	21
Donepezil Hcl	Donepezil Hcl	23	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	23	suppressed
Trazodone Hcl	Trazodone Hcl	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Acyclovir	Acyclovir	21	suppressed
Dulera	Mometasone/Formoterol	21	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Colchicine	Colchicine	20	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	20	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Clotrimazole	Clotrimazole	18	suppressed
Cyclosporine	Cyclosporine	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Prednisone	Prednisone	18	17
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Icosapent Ethyl	Icosapent Ethyl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Repaglinide	Repaglinide	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	14	14
Acarbose	Acarbose	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Atrovent Hfa	Ipratropium Bromide	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Elmiron	Pentosan Polysulfate Sodium	12	suppressed
Linzess	Linaclotide	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Proctosol-Hc	Hydrocortisone	12	suppressed
Dutasteride	Dutasteride	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Probenecid	Probenecid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error